Abstract
We report a 10-year-old male with widespread recurrent Burkitt's lymphoma who underwent successful mismatched unrelated cord blood transplantation (UCBT) following salvage chemotherapy. He was conditioned with TBI, antithymocyte globulin (ATG) and high-dose VP-16 and achieved full donor engraftment. He experienced grade II skin and grade I gastrointestinal acute GVHD with no chronic GVHD. He is alive with no evidence of disease 24 months following UCBT. Bone Marrow Transplantation (2000) 25, 1311–1313.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shad A, Magrath I . Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology Lippincott-Raven: Philadelphia 1997 545–587
Ladenstein R, Pearce R, Hartmann O et al. High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry Blood 1997 90: 2921–2930
Jones RJ, Ambinder RF, Piantadosi S, Santos GW . Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation Blood 1991 77: 649–653
Lundberg JH, Hansen RM, Chitambar CR et al. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors J Clin Oncol 1991 9: 1848–1859
Bureo E, Ortega JJ, Muñoz A et al. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma Bone Marrow Transplant 1995 3: 353–359
Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma Blood 1994 84: 1050–1055
Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors New Engl J Med 1997 337: 373–381
Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577
Harris DT . In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood Bone Marrow Transplant 1995 15: 17–23
Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease Blood 1996 88: 795–802
Goldman SG, Munoz L, Lenarsky C, Weinthal J . TBI/VP-16 with ATG is sufficient for sustained engraftment following mismatched unrelated cord blood transplantation in children with high risk leukemia and lymphoma. Presented at the Fifth Annual Marrow Transplantation in Children Conference, Hilton Head, South Carolina, February 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinthal, J., Goldman, S. & Lenarsky, C. Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant 25, 1311–1313 (2000). https://doi.org/10.1038/sj.bmt.1702428
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702428